Preliminary comments on proteasome inhibition and cardiovascular disease

ISSN： 0946-2716

Source： Journal of Molecular Medicine, Vol.87, Iss.8, 2009-08, pp. : 749-751

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The potential for CETP inhibition to reduce cardiovascular disease risk

By Ansell Benjamin Hobbs F. D. Richard

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2467-2478

Informa Healthcare

Access to resources Recommend Favorite

Proteasome Inhibition: Novel Therapy for Multiple Myeloma

Oncology Research and Treatment, Vol. 29, Iss. 4, 2006-03 ,pp. : 162-168

Karger

Access to resources Recommend Favorite

Alcohol industry funding effects

DRUG AND ALCOHOL REVIEW, Vol. 34, Iss. 1, 2015-01 ,pp. : 58-66

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potent anti-inflammatory effects of low-dose proteasome inhibition in the vascular system

By Ludwig Antje

Journal of Molecular Medicine, Vol. 87, Iss. 8, 2009-08 ,pp. : 793-802

Springer Publishing Company

Access to resources Recommend Favorite

The role of osteoprotegerin in cardiovascular disease

By Montagnana Martina

Annals of Medicine, Vol. 45, Iss. 3, 2013-05 ,pp. : 254-264

Informa Healthcare

Access to resources Recommend Favorite